Welcome to our dedicated page for Ifabric news (Ticker: IFABF), a resource for investors and traders seeking the latest updates and insights on Ifabric stock.
iFabric Corp. reports developments in technology-enhanced apparel and intelligent fabrics through its wholly owned subsidiary Intelligent Fabric Technologies (North America) Inc. Company updates frequently cover medical apparel programs such as Doctor's Choice scrubs and Frontline scrubs, along with proprietary textile technologies including PROTX2 antimicrobial treatment, ecoPEL fluorine-free durable water repellent technology, and DryTX moisture management.
Recurring news also includes financial results, revenue outlooks, retailer program expansions, and new product categories that apply IFTNA technologies to performance apparel, footwear, bedding, and other finished goods. The company's public updates also reference brand and retail programs including Verzus All Apparel, Roots branded footwear, and the Coconut Grove subsidiary within iFabric's broader operating structure.
iFabric Corp (OTCQX:IFABF) announced the expansion of its PROTX2 technology into the United Kingdom and European Union markets, marking a significant strategic expansion beyond North America. The company has secured a notable partnership with Marks & Spencer, which will incorporate PROTX2 technology into select items within its Autograph collections.
The PROTX2 brand mark will be prominently featured on merchandise hang tags both in-store and online, increasing brand visibility in these new regional markets. The company's Intelligent Fabric Technologies Division will support production programs incorporating PROTX2 technology in both the EU and UK regions.
iFabric Corp (OTCQX:IFABF) has announced the publication of groundbreaking clinical trial results in the Journal of Hospital Infection, demonstrating the effectiveness of their PROTX2® and ecoPEL™ antimicrobial technologies in healthcare settings.
The trial, conducted at MemorialCare Saddleback Medical Center, is the first successful antimicrobial textile trial to show statistically significant bacterial load reductions on scrubs in a real-world healthcare environment. The study validates that scrubs treated with PROTX2® and PROTX2® combined with ecoPEL™ significantly reduce surface bacterial contamination compared to untreated scrubs.
PROTX2® is EPA-registered and available for use throughout the United States, positioning IFTNA as a leader in healthcare-associated infection prevention solutions.
iFabric Corp (OTCQX:IFABF) reported its Q2 and H1 2025 financial results, with Q2 revenues remaining flat at $5.8 million compared to 2024. The company's H1 2025 revenues increased by 5% to $12.9 million. Q2 gross profit margin decreased to 37% from 42% in 2024, primarily due to $350,000 in brand advertising contributions.
The Intimate Apparel Division showed growth with a 10% revenue increase, while the Intelligent Fabrics Division saw a 7% decrease. The company reported a Q2 2025 net loss of $190,103 ($0.006 per share) compared to net earnings of $56,103 in 2024. Working capital remained strong at $19.2 million, with an unused $12 million credit facility available for future growth.
iFabric (OTCQX:IFABF) held its 2025 Annual General Meeting with approximately 65% shareholder participation, representing 19.5 million shares. All proposed matters received majority approval. The election of directors saw overwhelming support, with all six nominees receiving over 98.85% approval.
Shareholders also approved the appointment of BDO Canada LLP as auditors and fixed the number of directors at six. Notable directors Hylton Karon and Richard Macary received 99.86% and 99.94% of votes in favor, respectively.
iFabric Corp (IFABF) reported record Q1 2025 revenues of $7.08 million, a 5% increase from Q1 2024. The Intelligent Fabrics Division saw a 25% revenue increase to $5.82 million, while the Intimate Apparel Division experienced a 40% decrease to $1.25 million. Gross profit margins declined to 39% from 44%, resulting in a net earnings decrease to $88,458 ($0.003 per share) from $550,596 ($0.018 per share) in Q1 2024.
The company faces increased U.S. tariffs on Chinese imports (30%, up 10%), affecting 23% of total revenue. Cash position strengthened to $5.64 million, and the company expanded its bank operating line to $12 million. Management anticipates continued momentum and new product segments launch later in 2025, despite regulatory costs and ongoing leaching study expenses for Protx2.
iFabric Corp (IFABF) has announced two significant financial developments: First, the acquisition of the remaining 25% stake in its Markham, Ontario warehouse property subsidiary through a CDN$3.7 million mortgage financing from BMO. This financing will also be used to repay existing secured and minority shareholder loans.
Second, the company has secured a new banking agreement with BMO that increases its revolving operating credit facility from $6.75 million to $12 million. The facility, currently unutilized, is secured by company assets including a mortgage on the Markham property, which was recently valued at approximately $12 million.
iFabric Corp (IFABF) reported record financial results for Q4 and full year 2024. Q4 revenues reached a record $10.5 million, up 55% year-over-year, driven by new apparel programs. The company achieved Q4 gross profit of $4.17 million (40% margin) and Adjusted EBITDA of $1.9 million, a 636% increase.
For full-year 2024, revenues totaled $27.3 million, with the Intelligent Fabrics division growing 25% and Intimate Apparel division up 11% on a proportionate basis. Net earnings were $1.63 million ($0.054 per share) compared to a loss in 2023. Working capital improved to $19.6 million, with cash position strengthening to $2.06 million.
The company maintains a strong financial position with an unutilized $6.75 million bank operating line and expects continued double-digit sales growth in 2025, supported by new product categories and strong baseline sales from core programs.
iFabric Corp (TSX:IFA, OTCQX:IFABF) has reported its fifth consecutive year of revenue growth, with the last two years showing strong double-digit increases. The company achieved record revenues exceeding $27 million in full-year 2024, representing a 20% increase from the previous year.
Despite the strong performance, revenues fell slightly under $1 million below management's target range due to the Vancouver Port strike affecting Q4 deliveries. Nevertheless, Q4 2024 marked the largest single-quarter performance in the company's history. The delayed shipments are scheduled for delivery in Q1 2025.
iFabric Corp reported Q3 2024 results with revenues decreasing 11% to $4.28M compared to $4.81M in 2023. The Intelligent Fabric Division saw a 29% revenue decrease, while the Intimate Apparel Division grew 42%. Gross profit margin improved to 41% from 37%. The company maintains its FY2024 outlook of $28M-$32M, with Q4 revenue expected to exceed $11M. A potential Vancouver port strike could impact Q4 deliveries. Working capital stood at $17.5M, with cash increasing to $4.09M. The company reported a net loss of $105,616 ($0.003 per share) compared to $139,545 loss in 2023.